Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids.
about
Effect of antioxidant protection by p-coumaric acid on low-density lipoprotein cholesterol oxidationThe in vivo gene expression signature of oxidative stressPathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activationOxidative stress and nucleic acid oxidation in patients with chronic kidney diseaseOxidized PLs and vascular inflammationSustained Isoprostane E2 Elevation, Inflammation and Fibrosis after Acute Ischaemia-Reperfusion Injury Are Reduced by Pregnane X Receptor ActivationBioanalytical techniques for detecting biomarkers of response to human asbestos exposureNeurofurans, novel indices of oxidant stress derived from docosahexaenoic acidCharacterization of the effects of isoprostanes on platelet aggregation in human whole bloodGeneration and biological activities of oxidized phospholipidsThe effects of oxidative stress on female reproduction: a reviewClinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosisMeasurement of Lipid PeroxidationThe effect of oxidized phospholipids on phenotypic polarization and function of macrophages.The role of oxidized phospholipids in atherosclerosis.Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view.Targeted quantitative analysis of eicosanoid lipids in biological samples using liquid chromatography-tandem mass spectrometry.The isoprostanes: unique prostaglandin-like products of free-radical-initiated lipid peroxidation.Oxidative risk for atherothrombotic cardiovascular disease.Measurement of isoprostanes as markers of oxidative stress in neuronal tissue.No effect of 14 day consumption of whole grain diet compared to refined grain diet on antioxidant measures in healthy, young subjects: a pilot study.Rat brain endothelial cells are a target of manganese toxicityCyclopentenone eicosanoids as mediators of neurodegeneration: a pathogenic mechanism of oxidative stress-mediated and cyclooxygenase-mediated neurotoxicity.Cyclopentenone isoprostanes are novel bioactive products of lipid oxidation which enhance neurodegenerationEx vivo oxidation in tissue and plasma assays of hydroxyoctadecadienoates: Z,E/E,E stereoisomer ratios.Oxidative stress may explain how hypertension is maintained by normal levels of angiotensin II.Urinary 15-F2t-isoprostane, aflatoxin B1 exposure and hepatitis B virus infection and hepatocellular carcinoma in Taiwan.Treating gout with pegloticase, a PEGylated urate oxidase, provides insight into the importance of uric acid as an antioxidant in vivo.ω-Alkynyl lipid surrogates for polyunsaturated fatty acids: free radical and enzymatic oxidations.Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy.Interaction between oxidative stress and high-density lipoprotein cholesterol is associated with severity of coronary artery calcification in rheumatoid arthritis.Formation of non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro.Nonenzymatic free radical-catalyzed generation of 15-deoxy-Δ(12,14)-prostaglandin J₂-like compounds (deoxy-J₂-isoprostanes) in vivo.Discovery of lipid peroxidation products formed in vivo with a substituted tetrahydrofuran ring (isofurans) that are favored by increased oxygen tension.Whole-body cryostimulation--potential beneficial treatment for improving antioxidant capacity in healthy men--significance of the number of sessions.Omega-3 fatty acid oxidation products prevent vascular endothelial cell activation by coplanar polychlorinated biphenyls.F3-Isoprostanes as a Measure of in vivo Oxidative Damage in Caenorhabditis elegansVitamin C supplementation lowers urinary levels of 4-hydroperoxy-2-nonenal metabolites in humansAssessment of antioxidant reserves and oxidative stress in cerebrospinal fluid after severe traumatic brain injury in infants and children.Singlet oxygen induced products of linoleates, 10- and 12-(Z,E)-hydroxyoctadecadienoic acids (HODE), can be potential biomarkers for early detection of type 2 diabetes.
P2860
Q23923196-8C37E313-5E65-499A-BE6E-2CE1C359F0A4Q24653033-DF089AC7-4DA5-4BA3-8A68-C030FAF6C93BQ26864770-9D0026DD-B186-4013-81DE-6C19D8BA246FQ27006908-F5B1C3BE-0DC8-4009-B40B-D0EA59957E05Q27013971-503DD2C5-1211-480F-95AF-88DE72D3E85FQ27322581-2C6EB563-D189-48E2-830A-889B2D58BEABQ28082088-0995DB9A-1056-4B01-BE5D-A68454D6B3A5Q28252451-61E6258B-5EA6-4725-AF5E-BFA070A4BFFDQ28363028-BEAD4CF9-B9BD-466C-BAC5-4A19D4788073Q28389691-15215C7B-5957-4016-ADE2-47E2B3B935CAQ28392215-93F8B467-0609-4631-BFC7-D44A49BFF38DQ28392768-9F08D3D6-0791-477B-8D34-A86569ABA696Q30050243-47F1C32B-DD80-446E-9701-32081263B6BAQ30268532-6417C350-FB7A-4229-A2BC-E2F47A942F9DQ30436606-B84ABCAE-2113-4064-A93A-DF8D7CAB1076Q33350202-6DFE8476-42E8-4007-96A2-35C5E000BD14Q33442367-92D850CA-FCFB-4B55-A0A2-0E4CB3FB206FQ33538228-AF436E9C-F6E0-4F08-92EE-814336896355Q33554184-8097A2EE-F99E-4F31-9675-A530D87E4355Q33688993-5C5FD412-43BC-43D4-A7B3-ED320D8585AAQ33758700-92B40DDD-4C7A-425D-A7AA-CC4CCF456BBBQ33770822-2DBCD44D-B9F1-48AF-8737-43B25A7F6D57Q33896920-7B6F4406-789D-42EB-9419-766186C0593CQ33896926-1A44A823-F902-4F47-90B1-862D5DA4A1C0Q33918421-B8A4B7DF-91D1-40F7-82FF-2F38F1B8E9D2Q33928307-11F9AA13-D5CF-4832-B6D4-124EAFEB89F2Q33986238-8BF1AE45-C7E8-4761-9325-9AFAB4CD8C47Q34069534-A118555E-55E9-4F1D-A428-6FB9318A516CQ34074547-1827E891-8769-4C27-9D23-83351F55B970Q34103169-136158BF-C00E-4E63-8B24-F9D85BE65E8FQ34104339-D8AC33EA-6953-4759-A08E-252F6C147D2FQ34131085-617F433A-E0F6-4FD4-A901-F941EA8971B8Q34395104-DC32EF1D-0C63-43CD-A8F7-9034359456AEQ34429657-867F6ECD-B0DC-4125-B793-65DBC6BC6A72Q34450334-31390C1C-F5AE-48D4-9C66-DCB28B6A107FQ34516600-AE380081-A3DE-4D50-AAEB-9FEF053E9C6AQ34592437-78F0CB5E-20AA-4449-BDA8-F599649E4541Q34612898-5B386DC2-97B3-4345-AF6D-12864F6485DAQ34616166-02B93404-7458-4055-B72C-5EA78FAEDA7AQ34730639-2AD4FB79-BA62-4E89-B3FE-32010D31C733
P2860
Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Non-cyclooxygenase-derived pro ...... rmed in situ on phospholipids.
@en
Non-cyclooxygenase-derived prostanoids
@nl
type
label
Non-cyclooxygenase-derived pro ...... rmed in situ on phospholipids.
@en
Non-cyclooxygenase-derived prostanoids
@nl
prefLabel
Non-cyclooxygenase-derived pro ...... rmed in situ on phospholipids.
@en
Non-cyclooxygenase-derived prostanoids
@nl
P2093
P2860
P356
P1476
Non-cyclooxygenase-derived pro ...... rmed in situ on phospholipids.
@en
P2093
P2860
P304
10721-10725
P356
10.1073/PNAS.89.22.10721
P407
P577
1992-11-01T00:00:00Z